Clinical Outcomes of Immune Checkpoint Inhibitors in Unique Cohorts Underrepresented in Clinical Trials.
Shah NJ, Della Pia A, Wu T, Williams A, Weber M, Sinclaire B, Gourna Paleoudis E, Alaoui A, Lev-Ari S, Adams S, Kaufman J, Parikh SB, Tonti E, Muller E, Serzan M, Cheruku D, Lee A, Sridhar A, Hee BTP, Ahn J, Pecora A, Ip A, Atkins MB.
Shah NJ, et al. Among authors: adams s.
Cancers (Basel). 2024 Jun 14;16(12):2223. doi: 10.3390/cancers16122223.
Cancers (Basel). 2024.
PMID: 38927928
Free PMC article.